Merck
CN
  • Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?

Lamotrigine in epilepsy, pregnancy and psychiatry--a drug for all seasons?

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia (2012-10-06)
Frank J E Vajda, Seetal Dodd, David Horgan
摘要

Lamotrigine has been demonstrated to be effective as both an antiepileptic drug and a mood stabiliser. For epilepsy it is less efficacious than valproate in primary generalised epilepsy, but it is comparable to some traditional drugs in partial epilepsy. In psychiatry it has significant advantages over other mood stabilisers for the treatment and prevention of depressive phases of bipolar illness, but not for the treatment of mania. It has a more benign adverse effect profile than older antiepileptic agents and is not a proven teratogen. Risk of adverse reactions is reduced by commencing treatment at a markedly reduced dose that is gradually increased.

材料
货号
品牌
产品描述

Supelco
拉莫三嗪, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
拉莫三嗪, ≥98%, powder
Supelco
Lamotrigine solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
USP
拉莫三嗪, United States Pharmacopeia (USP) Reference Standard
拉莫三嗪, European Pharmacopoeia (EP) Reference Standard
拉莫三嗪, European Pharmacopoeia (EP) Reference Standard
峰鉴别用拉莫三嗪, European Pharmacopoeia (EP) Reference Standard